Updated 06:11 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,883.00 +0.78% CL 84.99 -0.85% BTC 64,683.65 -0.95%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,883 +0.78% BTC $64,684 −0.95% VIX 22.91 +18.70% latest tape · as of 06:11 UTC
The Screen · Technology · Electronic Components

discoverIE Group plc

DSCV.L · LSE · GBp · Market cap $78.6B · 4,600 employees

discoverIE Group plc designs, manufactures, and supplies specialist electronic components for industrial applications in the United Kingdom, Europe, North America, Asia, and internationally.

FAIL · Does not pass the screen
788.00 GBp

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 06:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price788.00 GBp at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: 456.02 GBp to 524.42 GBp, base estimate 456.02 GBp (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price788.00 GBp
Fair value456.02
Ethical score70.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-16Read Markup788.00+0.0% to today ✓Distribution gives way to Markup first Markup read since November
2026-11-09Read Distribution771.00+2.2% to today Markup gives way to Distribution after a 7% slide in 7 days
2026-11-02Read Markup826.00-4.6% to today Distribution gives way to Markup first Markup read since October
2026-10-26Read Distribution809.00-2.6% to today ✓Markup gives way to Distribution while volume still accumulates

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

discoverIE Group plc holds its Markup at $788.00. Elevated stress, defensive posture warranted, held for 48 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 48 days
Price at the screen$788.00
Valuation2,789.66 trailing · 1,748.32 forward price to earnings
Values screenFAIL · score 70.0
Beta1.23
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 34.52% Below 33% Interest-bearing debt is 34.5% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 28.61% Below 49% Money owed to the company is 28.6% of assets, under the 49% limit. Pass
Revenue purity 0.61% Below 5% Only 0.6% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

discoverIE's business is in a permissible area, but its interest-bearing debt is about 35% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when DSCV.L's ethical verdict changes

Today DSCV.L does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our 456.02 GBp fair value estimate, 7.10% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

456.02Conservative456.02Base case524.42Growth case 788.00Price

Fair value range in GBp, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 72.8% above the base estimate.

The Street's Range
685.00Street low 900.00Street average 1,110.00Street high 788.00Price

Third-party analyst targets: 10 covering, consensus Strong Buy. The average target sits +14% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Projections

Where our models see it going: fair-value estimate 456.02 GBp, with a range of 456.02 GBp to 524.42 GBp, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 1,748.3x forward earnings, the price already runs ahead of the business. It trades 73% above our 456.02 GBp fair value, so you would be buying at a premium, not a discount.

The fundamentals · plain-English read
Forward P/E1,748.3xexpensive even after accounting for its growth
Trailing P/E2,789.7xexpensive: the price assumes strong growth ahead
EPS, trailing0.29
EPS, forward0.46
Revenue growth+7.1%slow but positive growth
Profit margin6.5%thin but positive margins
Return on equity9.1%a modest return on shareholder capital
FCF yield6.60%
Dividend yield1.67%
Debt to equity0.73moderate, manageable leverage
Current ratio1.45adequate liquidity, worth monitoring
Beta1.23moves a little more than the market
52-week range505.00 - 800.00
Market cap$78.6B
Employees4,600

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

DSCV.L trades on LSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-16 Markup · changed $788.00 +2.2% Entry 11

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-11-09 Distribution · changed $771.00 -6.7% Entry 10

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-11-02 Markup · changed $826.00 +2.1% Entry 9

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-10-26 Distribution · changed $809.00 +0.0% Entry 8

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-10-16 Markup $809.00 +0.0% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-10-02 Markup · changed $809.00 +15.7% Entry 6

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 15.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890. Since the last review it its composite score eased.

2026-08-27 Markdown · changed $699.00 +0.0% Entry 5

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-07-26 Markup · changed $699.00 +0.0% Entry 4

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-07-18 Accumulation $699.00 +0.0% Entry 3

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (10 analysts) rates it strong buy, with a mean price target of $890.

2026-07-03 Accumulation $699.00 +0.0% Entry 2

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $682.00 +0.4% · $1,004 +0.4%
2 months $578.00 +18.5% · $1,185 +18.5%
3 months $574.00 +19.3% · $1,193 +19.3%
6 months $587.00 +16.7% · $1,167 +16.7%
1 year $675.87 +1.4% $12.65 $1,032 +3.2%
2 years $717.73 -4.6% $24.80 $989 -1.1%
3 years $911.53 -24.9% $36.45 $791 -20.9%
5 years $876.38 -21.8% $50.80 $840 -16.0%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever DSCV.L does next, these words stay.

discoverIE Group plc · DSCV.L · Markup · $788.00
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.